INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 211 filers reported holding INSMED INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $690,000 | -39.0% | 20,256 | -40.4% | 0.00% | -40.0% |
| Q4 2020 | $1,131,000 | +2.5% | 33,967 | -1.0% | 0.01% | 0.0% |
| Q3 2020 | $1,103,000 | +23.2% | 34,314 | +5.6% | 0.01% | +25.0% |
| Q2 2020 | $895,000 | +36.2% | 32,484 | -20.8% | 0.00% | 0.0% |
| Q1 2020 | $657,000 | +9.3% | 41,014 | +62.9% | 0.00% | +33.3% |
| Q4 2019 | $601,000 | +58.2% | 25,183 | +16.9% | 0.00% | +50.0% |
| Q3 2019 | $380,000 | -27.6% | 21,538 | +5.1% | 0.00% | -33.3% |
| Q2 2019 | $525,000 | -11.9% | 20,498 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $596,000 | +169.7% | 20,498 | +22.0% | 0.00% | +200.0% |
| Q4 2018 | $221,000 | -82.9% | 16,808 | -73.7% | 0.00% | -85.7% |
| Q3 2018 | $1,292,000 | -33.9% | 63,873 | -22.7% | 0.01% | -36.4% |
| Q2 2018 | $1,955,000 | +16.9% | 82,680 | +11.3% | 0.01% | +22.2% |
| Q1 2018 | $1,673,000 | +411.6% | 74,280 | +124.1% | 0.01% | +200.0% |
| Q2 2016 | $327,000 | – | 33,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
| Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
| Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
| MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
| Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
| Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
| GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
| Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
| SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |